Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area mapk mek1 2'

Search results for: 'research area mapk mek1 2'

Items 311-320 of 765

Page
per page
  1. (S)-PFI-2 (hydrochloride)
    C4834 (S)-PFI-2 (hydrochloride)
    Summary: Negative control of (R)-PFI 2 hydrochloride
      ≤0.5 mg/mL
  2. ACTH (1-39)
    B5434 ACTH (1-39)
    Summary: melanocortin receptor 2 (MC2) agonist
      Soluble to 1 mg/mL
  3. M 1145
    B5464 M 1145
    Summary: galanin receptor 2 (GAL2) agonist
      Soluble to 5 mg/mL
  4. TC-S 7005
    B5604 TC-S 7005
    Summary: polo-like kinase 2 (PLK2) inhibitor
      <35.94 mg/mL
  5. L-365,260
    B7181 L-365,260
    Summary: cholecystokinin receptor 2 (CCK2) antagonist
      <39.85 mg/mL
  6. ABC294640
    B1182 ABC294640
    Target: SK
    Summary: Sphingosine kinase 2 inhibitor,selective and competitive
      ≥38.1 mg/mL
  7. Cdk2/Cyclin Inhibitory Peptide I
    A1107 Cdk2/Cyclin Inhibitory Peptide I
    Summary: Cell division protein kinase 2
      ≥257.1 mg/mL
  8. GLX481304
    BA8041 GLX481304
    Summary: GLX481304 is a specific inhibitor of -2 and -4.
  9. Streptomycin
    A9080 Streptomycin
    Summary: Streptomycin (Agrept) is an antibiotic effective against M. tuberculosis and is widely used in tuberculosis (TB) research.
      insoluble in DMSO; insoluble in EtOH; ≥53.6 mg/mL
  10. SMIFH2
    B5577 SMIFH2
    Summary: formin homology 2 (FH2) domains inhibitor
      <37.72 mg/mL

Items 311-320 of 765

Page
per page
Shop By
Shopping Options
Category
  1. Signaling Pathways152item
  2. Natural Products2item
  3. Amino Acids & Building Blocks1 item
  4. Protein12item
  5. Kits4item
  6. Screening Library34item
  7. Modified Nucleotides2item
  8. HyperScribe™ All in One mRNA Synthesis Kit1 item
  9. Peptides2item
  10. Molecular Biology9item
  11. Cell Biology22item
  12. Peptides & Proteins60item
  13. Protein & Immunology6item
  14. Cell culture1 item
  15. Antibody144item
  16. Biochemical Reagent329item
Specificity
  1. Selective43item
Reversibility
  1. Reversible3item
Target
  1. Cyclin-Dependent Kinases4item
  2. Histone Deacetylases (HDACs)2item
  3. Akt1 item
  4. PI3K2item
  5. Raf2item
  6. Aurora Kinases1 item
  7. EZH21 item
  8. mTOR4item
  9. MMP1 item
  10. FLT32item
  11. PLK1 item
  12. Eph Receptors1 item
  13. VEGFR9item
  14. PDGFR2item
  15. c-Kit1 item
  16. p385item
  17. PKB1 item
  18. Bcr-Abl2item
  19. MEK7item
  20. FGFR2item
  21. MET1 item
  22. Src2item
  23. Trk Receptors2item
  24. EGFR2item
  25. PD-1/PD-L1 interaction1 item
  26. JAK1 item
  27. EZH11 item
  28. DNA-PK2item
  29. DNA Methyltransferases1 item
  30. c-MET1 item
  31. PKC1 item
  32. SGLT1 item
  33. HER21 item
  34. LRRK22item
  35. Insulin and Insulin-like Receptors1 item
  36. PARP1 item
  37. ALK1 item
  38. PKG1 item
  39. PKA1 item
  40. Tie-22item
  41. ATM/ATR1 item
  42. COX1 item
  43. P1101 item
  44. Hck1 item
  45. Cytidine deaminases1 item
  46. KDR1 item
  47. Fyn kinase1 item
  48. c-Fms tyrosine kinase1 item
  49. Ftase1 item
  50. Prk1 item
  51. DCLK21 item
  52. UCP1 item
  53. SK1 item
  54. reverse transcriptase1 item
Reported Experiments
  1. Animal Experiments52item
  2. Cell Experiments43item
Related Disease
  1. Acute Myeloid Leukemia2item
  2. Adrenocortical Carcinoma1 item
  3. Biliary Cancer1 item
  4. Bladder Cancer1 item
  5. Bladder Carcinoma2item
  6. Breast Cancer12item
  7. Cancer34item
  8. Cervical Cancer1 item
  9. Cholangiocarcinoma1 item
  10. Clear Cell Renal Cell Carcinoma1 item
  11. Colon Cancer5item
  12. Colorectal Cancer6item
  13. Diabetes1 item
  14. Glioblastoma3item
  15. HIV1 item
  16. Liver Cancer1 item
  17. Lung Cancer1 item
  18. Lymphoma1 item
  19. Melanoma4item
  20. Multiple Myeloma1 item
  21. Non-small Cell Lung Cancer5item
  22. Ovarian Cancer1 item
  23. Pancreatic Cancer5item
  24. Prostate Cancer1 item
  25. Renal Cell Carcinoma1 item
  26. Rheumatoid Arthritis1 item
  27. Thyroid Cancer2item
  28. Type 2 Diabetes1 item